SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引：0

作者：

Alonso-Gordoa, Teresa ^{[1
]}

Jimenez-Fonseca, Paula ^{[2
]}

Martinez-Trufero, Javier ^{[3
]}

Navarro, Miguel ^{[4
]}

Porras, Ignacio ^{[5
]}

Rubio-Casadevall, Jordi ^{[6
]}

Arregui Valles, Marta ^{[7
]}

Baste, Neus ^{[8
]}

Hernando, Jorge ^{[9
]}

Iglesias Docampo, Lara ^{[10
]}

机构：

[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain

[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain

[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain

[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain

[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain

[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain

[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain

[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain

[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain

[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;

D O I：

10.1007/s12094-024-03736-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.

引用

页码：2902 / 2916

页数：15

共 50 条

[21] SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
María José Méndez-Vidal
Martin Lázaro Quintela
Nuria Lainez-Milagro
Begoña Perez-Valderrama
Cristina Suárez Rodriguez
José Ángel Arranz Arija
Ignacio Peláez Fernández
Enrique Gallardo Díaz
Julio Lambea Sorrosal
Aránzazu González-del-Alba
Clinical and Translational Oncology, 2023, 25 : 2732 - 2748
[22] SEOM clinical guideline emesis (2021)
Majem, Margarita
de las Penas, Ramon
Antonio Virizuela, Juan
Cabezon-Gutierrez, Luis
Cruz, Patricia
Lopez-Castro, Rafael
Mendez, Miriam
Mondejar, Rebeca
del Mar Munoz, Maria
Escobar, Yolanda
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 712 - 723
[23] Clinical guideline SEOM: hepatocellular carcinoma
Sastre, J.
Diaz-Beveridge, R.
Garcia-Foncillas, J.
Guardeno, R.
Lopez, C.
Pazo, R.
Rodriguez-Salas, N.
Salgado, M.
Salud, A.
Feliu, J.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12) : 988 - 995
[24] SEOM-GECOD clinical guideline for unknown primary cancer (2021)
Losa, Ferran
Fernandez, Isaura
Etxaniz, Olatz
Gimenez, Alejandra
Gomila, Paula
Iglesias, Lara
Longo, Federico
Nogales, Esteban
Sanchez, Antonio
Soler, Gemma
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 681 - 692
[25] SEOM-GEICO Clinical Guidelines on cervical cancer (2023)
Manso, Luis
Ramchandani-Vaswani, Avinash
Romero, Ignacio
Sanchez-Lorenzo, Luisa
Bermejo-Perez, Maria Jose
Estevez-Garcia, Purificacion
Farina-Madrid, Lorena
Garcia, Yolanda Garcia
Gil-Martin, Marta
Quindos, Maria
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2771 - 2782
[26] SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016)
Munoz, M.
Santaballa, A.
Segui, M. A.
Beato, C.
de la Cruz, S.
Espinosa, J.
Fonseca, P. J.
Perez, J.
Quintanar, T.
Blasco, A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12) : 1229 - 1236
[27] Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing
Elisei, Rossella
Romei, Cristina
ENDOCRINE, 2023, 81 (02) : 206 - 215
[28] SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)
Rivas, Ainara Soria
Alvarez, Yolanda Escobar
Cordellat, Ana Blasco
Tarruella, Margarita Majem
Mata, Kevin Molina
Sanchez, M. del Mar Munoz
de la Camara, Marta Motilla
Poves, Marta Zafra
Zambrano, Carmen Beato
Gutierrez, Luis Cabezon
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2866 - 2876
[29] SEOM-GEM clinical guidelines for cutaneous melanoma (2023)
Marquez-Rodas, Ivan
Couselo, Eva Munoz
Moreno, Juan F. Rodriguez
Fernandez, Ana Ma Arance
Guerrero, Miguel Angel Berciano
Balea, Begona Campos
Merino, Luis de la Cruz
Arranz, Enrique Espinosa
Castano, Almudena Garcia
Jaime, Alfonso Berrocal
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2841 - 2855
[30] Summary and update on the management of differentiated thyroid cancer in 2023
Raymond, Perrine
Klein, Marc
Borson-Chazot, Francoise
ANNALES D ENDOCRINOLOGIE, 2024, 85 (02) : 110 - 117

← 1 2 3 4 5 →